Becloforte
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Beclometasone dipropionate 250ug (63mg per can ,includes 5% manufacturing overage)
Disponibbli minn:
GlaxoSmithKline NZ Limited
INN (Isem Internazzjonali):
Beclometasone dipropionate 250 µg (63mg per can ,includes 5% manufacturing overage)
Dożaġġ:
250 mcg/dose
Għamla farmaċewtika:
Aerosol inhaler, metered dose
Kompożizzjoni:
Active: Beclometasone dipropionate 250ug (63mg per can ,includes 5% manufacturing overage) Excipient: Dichlorodifluoromethane Oleic acid Trichlorofluoromethane
Unitajiet fil-pakkett:
Inhaler, metered, 200 dose units
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Glaxo Operations UK Ltd
Sommarju tal-prodott:
Package - Contents - Shelf Life: Inhaler, metered, - 200 dose units - 36 months from date of manufacture stored at or below 30°C
Data ta 'l-awtorizzazzjoni:
1983-07-26
